Show simple item record

dc.contributor.authorSaleem, Azeem
dc.contributor.authorJackson, A
dc.contributor.authorMukherjee, S
dc.contributor.authorStones, N
dc.contributor.authorCrosby, T
dc.contributor.authorTait, D
dc.contributor.authorPrice, Patricia M
dc.date.accessioned2010-08-11T10:58:37Z
dc.date.available2010-08-11T10:58:37Z
dc.date.issued2010-05
dc.identifier.citationRadiotherapy in the management of unresectable locally advanced pancreatic cancer: a survey of the current UK practice of clinical oncologists. 2010, 22 (4):257-60 Clin Oncolen
dc.identifier.issn1433-2981
dc.identifier.pmid20223645
dc.identifier.doi10.1016/j.clon.2010.02.004
dc.identifier.urihttp://hdl.handle.net/10541/109479
dc.description.abstractA survey was conducted by the Academic Clinical Oncology and Radiobiology Research Network (ACORRN) to evaluate current radiotherapy practice and to inform future research needs in patients with locally advanced pancreatic cancer. A clear need for a co-ordinated multicentre approach, given the limited number of patients who may qualify for such UK trials, was identified. Such trials should incorporate evidence-based treatment protocols and appropriate quality assurance procedures to ensure delivery of the highest standards of radiation-based therapy within, and without, clinical trials.
dc.language.isoenen
dc.subjectPancreatic Canceren
dc.subject.meshClinical Trials as Topic
dc.subject.meshGreat Britain
dc.subject.meshHealth Surveys
dc.subject.meshHumans
dc.subject.meshMedical Oncology
dc.subject.meshPancreatic Neoplasms
dc.subject.meshPhysician's Practice Patterns
dc.titleRadiotherapy in the management of unresectable locally advanced pancreatic cancer: a survey of the current UK practice of clinical oncologists.en
dc.typeArticleen
dc.contributor.departmentUniversity of Manchester Academic Radiation Oncology, The Christie NHS Foundation Trust, Manchester, UK. azeem.saleem@manchester.ac.uken
dc.identifier.journalClinical Oncologyen
html.description.abstractA survey was conducted by the Academic Clinical Oncology and Radiobiology Research Network (ACORRN) to evaluate current radiotherapy practice and to inform future research needs in patients with locally advanced pancreatic cancer. A clear need for a co-ordinated multicentre approach, given the limited number of patients who may qualify for such UK trials, was identified. Such trials should incorporate evidence-based treatment protocols and appropriate quality assurance procedures to ensure delivery of the highest standards of radiation-based therapy within, and without, clinical trials.


Files in this item

This item appears in the following Collection(s)

Show simple item record